Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-08-21
1999-02-02
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
604 96, A61K 3156
Patent
active
058665617
ABSTRACT:
A method for inducing angiogenesis in blood vessels proximal to ischemic tissue or proximal to stenosed regions including application of an estrogen compound to the blood vessel walls at a treatment site proximal to or upstream of the stenosis. A preferred delivery device is a double walled drug delivery catheter having porous outer walls. Another suitable delivery device is a drug injection device for injecting angiogenic material into blood vessel walls. One delivery method utilizes iontophoresis.
REFERENCES:
patent: 5180366 (1993-01-01), Woods
patent: 5219739 (1993-06-01), Tischer et al.
patent: 5295962 (1994-03-01), Crocker et al.
patent: 5300679 (1994-04-01), Baylis et al.
patent: 5376652 (1994-12-01), Javitt
patent: 5389314 (1995-02-01), Wang
patent: 5395831 (1995-03-01), Gemmill, Jr. et al.
patent: 5425703 (1995-06-01), Feiring
patent: 5437864 (1995-08-01), Edgington et al.
patent: 5457113 (1995-10-01), Cullinan et al.
patent: 5462937 (1995-10-01), Cullinan et al.
patent: 5472985 (1995-12-01), Grainger et al.
patent: 5492926 (1996-02-01), Cullinan et al.
patent: 5516528 (1996-05-01), Hughes et al.
patent: 5538504 (1996-07-01), Linden et al.
patent: 5545569 (1996-08-01), Grainger et al.
patent: 5552395 (1996-09-01), Gemmill, Jr. et al.
patent: 5554119 (1996-09-01), Harrison et al.
patent: 5567828 (1996-10-01), Dodge
patent: 5580569 (1996-12-01), Giampapa
patent: 5580722 (1996-12-01), Foulkes et al.
patent: 5591129 (1997-01-01), Shoup et al.
Morales et al-Circulation, 91(3), 755-63 (Abstract), 1995.
Hyder et al-Cancer Lett. (Shannom Irel.), 120(2), 165-71 (Abstract), 1997.
The Encyclopedia of Molecular Biology, Sir John Kendrew, Blackwall Science, Copyright 1994, p. 1112.
Bruengger et al., "Smooth Muscle Cell of the Canine Prostate in Spontaneous Benign Hyperplasia, Steroid Induced Hyperplasia and Estrogen or Tamoxifen Treated Dogs", The Journal of Urology, vol. 130, No. 6, Dec. 1983, pp. 1208-1210.
Schwartz et al., "Nicotinic Cholinergic Receptor Binding Sites in the Brain: Regulation in vivo", Science, vol. 220, No. 4593, Apr. 1983, pp. 214-216.
Schenkman Leonard
Sci-Med Life Systems, Inc.
LandOfFree
Local delivery of estrogen for angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Local delivery of estrogen for angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Local delivery of estrogen for angiogenesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1117593